WS FIR officially entered Italy!
The Italian company, DIALMEDICA visited Taiwan in Oct 21st to 25th, during this visiting, DIALMEDICAL formally engaged with WS as the sole distributor of WS FIR in Italy. Since a new stronghold is established in Europe.
WS and DIALMEDICA first met in ERA-EDTA this May, both companies […]
Receiving the visiting group of Juntendo University in Japan
Dr. Yasuhiko Tomino, the Professor of Juntendo University in Japan, the President of Asian Pacific Society of Nephrology visited Taiwan during the 6th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (Sep 27th to 29th).
WS arranged the visiting group to HD center of Taipei Veterans […]
閱讀全文
New paper published-WS FIR improving fistula maturation.
A new paper published on AJKD (American Journal of Kidney Diseases) in August. This open-label randomized clinical trial subject to WS improving new HD fistula maturation was conducted in Taipei Veterans General Hospital. As fistula maturation remains a problem due to patients’ biology of the vessel, this […]
閱讀全文
WS visited the Dialysis Vascular Access Research Group of the University of Cincinnati
We visited the Dialysis Vascular Access Research Group of the University of Cincinnati in April to discuss the possibility of clinical trial in the US.
The research group is led by Dr. Prabir Roy-Chaudhury. Its members include nephrologist, vascular surgeons, vascular physiologists, radiologists and other interdisciplinary experts […]
閱讀全文